Health Care & Hospital Law
Jan. 21, 2012
Drugmakers look to FDA for guidance on off-label marketing
The FDA has only recently made an attempt to clarify its stance on what constitutes off-label marketing, the illegal promotion of drugs and medical devices for non-approved uses.
Daily Journal Staff Writer
Facing the loss of patent protection for their products, many pharmaceutical companies are exploring new uses for their drugs, even as federal prosecutors have stepped up enforcement of laws that prevent illegal promotion of unapproved uses.
Taken together, the two factors have converged to create a perfect storm for drug companies and medical device makers hoping to benefit patients and maximize pro...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In